Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuna Gu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Nuclear Medicine|September 5, 2025
Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer DiseaseSohyun Yim, Yuna Gu, Heekyung Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Integrating visual assessments and quantification methods for tau PET stagingYuna Gu, Jihwan Yun, Alexis Moscoso, et al.
JAMA Neurology|February 17, 2025
Temporal Dynamics and Biological Variability of Alzheimer BiomarkersJihwan Yun, Daeun Shin, Eun Hye Lee, et al.
JAMA Neurology|February 2, 2026
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and AnemiaJihwan Yun, Jungah Lee, Daeun Shin, et al.
JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGanna Blazhenets, Heather M Snyder, Liana G Apostolova, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Nuclear Medicine|September 5, 2025
Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer DiseaseSohyun Yim, Yuna Gu, Heekyung Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Integrating visual assessments and quantification methods for tau PET stagingYuna Gu, Jihwan Yun, Alexis Moscoso, et al.
JAMA Neurology|February 17, 2025
Temporal Dynamics and Biological Variability of Alzheimer BiomarkersJihwan Yun, Daeun Shin, Eun Hye Lee, et al.
JAMA Neurology|February 2, 2026
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and AnemiaJihwan Yun, Jungah Lee, Daeun Shin, et al.
JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGanna Blazhenets, Heather M Snyder, Liana G Apostolova, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 2